Amgen doubles down on BeiGene investment as Chinese biotech aims to raise $2.1B

13th July 2020 Uncategorised 0

Amgen doubles down on BeiGene investment as Chinese biotech aims to raise $2.1B
aliu
Mon, 07/13/2020 – 11:08




More: Amgen doubles down on BeiGene investment as Chinese biotech aims to raise .1B
Source: fierce